Skip to main content
SpringerLink
Log in

Hormonal aspects of sexual dysfunction: The therapeutic use of exogenous androgens in men and women

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

Hormones exert a pervasive influence on sexual activity. Androgens are involved in the initiation and maintenance of libido and spontaneous arousal. In recent years, the clinical use of exogenous androgens for treatment of sexual dysfunction has received a great deal of attention. Good evidence exists that such treatment is effective for arousal difficulties in men and women in the setting of a hypo-androgenic state. This article reviews the relationship between androgens and sexual function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. McEwen BS: Gonadal and adrenal steroids and the brain: implications for depression. In Hormones and Depression. Edited by Halbreich U. New York: Raven Press; 1998:239–253.

    Google Scholar 

  2. Rubinow DR, Schmidt PJ: Androgens, brain, and behavior. Am J Psychiatry 1996, 153:974–984.

    PubMed  CAS  Google Scholar 

  3. Sherwin BB, Gelfand MM: The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med 1987, 49:397–409.

    PubMed  CAS  Google Scholar 

  4. Laycock JF, Wise PH: Male reproductive endocrinology. In Essential Endocrinology, edn 3. New York: Oxford University Press; 1996.

    Google Scholar 

  5. Weinbauer GF, Gromoll J, Simoni M, Nieschlag E: Physiology of testicular function. In Andrology: Male Reproductive Health and Dysfunction. Edited by Nieschlag E, Behre H. Berlin: Springer-Verlag; 1997:25–60.

    Google Scholar 

  6. Bagatell CJ, Bremner WJ: Androgens in men-uses and abuses. N Engl J Med 1996, 334:707–714.

    Article  PubMed  CAS  Google Scholar 

  7. Bratt O, Borg A, Kristoffersson U, et al.: CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk. Br J Cancer 1999, 8:672–676.

    Article  CAS  Google Scholar 

  8. Schmidt PJ, Rubinow DR: Neuroregulatory role of gonadal steroids in humans. Psychopharmacol Bull 1997, 33:219–220.

    PubMed  CAS  Google Scholar 

  9. Seidman SN: The therapeutic uses of hormones in psychiatry. Psychiatric Ann 2000, 30:98–99.

    Google Scholar 

  10. Wolkowitz OM, Brizendine L, Reus VI: The role of dehydroepiandrosterone (DHEA) in psychiatry. Psychiatric Ann 1999, 30:123–128.

    Google Scholar 

  11. Rupprecht R: The neuropsychopharmacological potential of neuroactive steroids. J Psychiatr Res 1997, 31:297–314.

    Article  PubMed  CAS  Google Scholar 

  12. Morrison MF, Katz IR, Parmelee P, et al.: Dehydroepiandrosterone sulfate (DHEA-S) and psychiatric and laboratory measures of frailty in a residential care population. Am J Geriatr Psychiatry 1998, 6:277–284.

    PubMed  CAS  Google Scholar 

  13. Ravaglia G, Forti P, Maioli F, et al.: Determinants of functional status in healthy Italian nonagenarians and centenarians: a comprehensive functional assessment by the instruments of geriatric practice. J Am Geriatr Soc 1997, 45:1196–1202.

    PubMed  CAS  Google Scholar 

  14. Bagatell CJ, Heiman JR, Matsumoto AM, et al.: Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men. J Clin Endocrinol Metab 1994, 79:561–567.

    Article  PubMed  CAS  Google Scholar 

  15. Beach GA, Westbrook WH: Dissociation of androgen effects on sexual morphology and behavior in male rats. Endocrinology 1968, 83:395–398.

    PubMed  CAS  Google Scholar 

  16. Feder HH: Hormones and sexual behavior. Ann Rev Psychol 1984, 35:165–200.

    Article  CAS  Google Scholar 

  17. Valenti G: Psychoneuroendocrinology of aging: The brain as target organ of hormones. Psychoneuroendocrinology 1992, 14:2799–2282.

    Google Scholar 

  18. Kemper TD: Social Structure and Testosterone. New Brunswick: Rutgers University Press; 1990.

    Google Scholar 

  19. Money J, Schwartz M, Lewis VG: Adult erotosexual status and fetal hormonal masculinization and demasculinization: 46,XX congenital virilizing adrenal hyperplasia and 46, XY androgen-insensitivity syndrome compared. Psychoneuroendocrinology 1984, 9:405–414.

    Article  PubMed  CAS  Google Scholar 

  20. Berenbaum SA, Resnick SM: Early androgen effects on aggression in children and adults with congenital adrenal hyperplasia. Psychoneuroendocrinology 1997, 22:505–515.

    Article  PubMed  CAS  Google Scholar 

  21. Seidman SN, Rieder RO: A review of sexual behavior in the United States. Am J Psychiatry 1994, 151:330–341.

    PubMed  CAS  Google Scholar 

  22. Seidman SN, Roose SP: The hypothalamic-pituitary-gonadal axis and affective illness in men. In Hormones, Aging and Mental Disorders. Edited by Morrison M. Cambridge: Cambridge University Press; 2000: in press.

    Google Scholar 

  23. Gray A, Berlin JA, McKinlay JB, Longcope C: An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. J Clin Epidemiology 1991, 7:671–684.

    Article  Google Scholar 

  24. Plymate S, Tenover JS, Bremner WJ: Circadian variation in testosterone, sex hormonebinding globulin, and calculated nonsex hormonebinding globulin bound testosterone in healthy young and elderly men. J Androl 1989, 10:366–371.

    PubMed  CAS  Google Scholar 

  25. Mushayandebvu T, Castracane DV, Gimpel T, et al.: Evidence for diminished midcycle ovarian androgen production in older reproductive aged women. Fertil Steril 1996, 65:721–723.

    PubMed  CAS  Google Scholar 

  26. Zumoff B, Strain GW, Miller LK, Rosner W: Twenty-four hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab 1995, 80:1429–1430.

    Article  PubMed  CAS  Google Scholar 

  27. Longcope C, Franz C, Morello C, et al.: Steroid and gonadotropin levels in women during the peri-menopausal years. Maturitas 1986, 8:189–196.

    Article  PubMed  CAS  Google Scholar 

  28. McCoy NL, Davidson JM: A longitudinal study of the effects of menopause on sexuality. Maturitas 1985, 7:203–210.

    Article  PubMed  CAS  Google Scholar 

  29. Davis SR: The clinical use of androgens in female sexual disorders. J Sex Marital Ther 1998, 24:153–163. Comprehensive review of the use of androgens in women.

    Article  PubMed  CAS  Google Scholar 

  30. Laan E, van Lunsen RH: Hormones and sexuality in postmenopausal women: a psychophysiological study. J Psychosom Obstet Gynaecol 1997, 18:126–133.

    Article  PubMed  CAS  Google Scholar 

  31. Utian WH: The true clinical features of postmenopausal oophorectomy and their response to estrogen replacement therapy. S Afr Med J 1972, 46:732–737.

    PubMed  CAS  Google Scholar 

  32. Campbell S, Whitehead M: Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynecol 1977, 4:31–47.

    CAS  Google Scholar 

  33. Morrison MF, Tweedy K: Effects of estrogen on mood and cognition in aging women. Psychiatric Ann 2000, 30:113–119.

    Article  Google Scholar 

  34. Seidman SN, Rieder RO: Sexual behavior through the life cycle: an empirical approach. In American Psychiatric Press Review of Psychiatry, edn 14. Edited by Oldham J, Riba M. Washington, DC: American Psychiatric Press; 1995.

    Google Scholar 

  35. Davidsom JM, Rosen RC: Hormonal determinants of erectile function. In Erectile disorders: Assessment and treatment. Edited by Rosen RC, Leiblum SR. New York: Guilford Press; 1992:72–95.

    Google Scholar 

  36. Plymate S: Hypogonadism. Endocrinol Metab Clin N Am 1994, 23:749–772.

    CAS  Google Scholar 

  37. Anderson RA, Bancroft J, Wu FC: The effects of exogenous testosterone on sexuality and mood of normal men. J Clin Endocrinol Metab 1992, 75:1503–1507.

    Article  PubMed  CAS  Google Scholar 

  38. Bagatell CJ, Heiman JR, Rivier JE, Bremner WJ: Effects of endogenous testosterone and estradiol on sexual behavior in normal young men. J Clin Endocrinol Metab 1994, 78:711–716.

    Article  PubMed  CAS  Google Scholar 

  39. Rosler A, Witzum E: Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone. N Engl J Med 1998, 338:416–422.

    Article  PubMed  CAS  Google Scholar 

  40. Schiavi RC, White D, Mandeli J, Levine AC: Effect of testosterone administration on sexual behavior and mood in men with erectile dysfunction. Arch Sex Behav 1997, 26:231–241.

    Article  PubMed  CAS  Google Scholar 

  41. Benkert O, Witt W, Adam W, Leitz A: Effects of testosterone undecanoate on sexual potency and the hypothalamicpituitary-gonadal axis of impotent males. Arch Sex Behav 1979, 8:471–479.

    Article  PubMed  CAS  Google Scholar 

  42. O’Carroll R, Bancroft J: Testosterone therapy for low sexual interest and erectile dysfunction in men: a controlled study. Br J Psychiatry 1984, 145:146–151.

    Article  PubMed  CAS  Google Scholar 

  43. Carani C, Zini D, Baldini A, et al.: Effect of androgen treatment in impotent men with normal and low levels of free testosterone. Arch Sex Behav 1990, 19:223–234.

    Article  PubMed  CAS  Google Scholar 

  44. Rabkin JG, Wagner G, Rabkin R: A double-blind, placebocontrolled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. Arch Gen Psychiatry 2000, 57:141–147.

    Article  PubMed  CAS  Google Scholar 

  45. Tricker R, Casaburi R, Storer TW, et al.: The effects of supraphysiological doses of testosterone on angry behavior in healthy eugonadal men—a clinical research center study. J Clin Endocrinol Metab 1996, 81:3754–3758.

    Article  PubMed  CAS  Google Scholar 

  46. Matsumoto AM: Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production. J Clin Endocrinol Metab 1990, 70:282–287.

    PubMed  CAS  Google Scholar 

  47. Janowsky JS, Oviatt SK, Orwoll ES: Testosterone influences spatial cognition in older men. Behav Neurosci 1994, 108:325–332.

    Article  PubMed  CAS  Google Scholar 

  48. Rinieris PM, Malliaras DE, Batrinos ML, Stefanis CN: Testosterone treatment of depression in two patients with Klinefelter’s syndrome. Am J Psychiatry 1979, 136:986–988.

    PubMed  CAS  Google Scholar 

  49. Danziger L, Schroeder HT, Unger AA: Androgen therapy for involutional melancholia. Arch Neurol Psychiatry 1944, 51:457–461.

    Google Scholar 

  50. Altschule MD, Tillotson KJ: The use of testosterone in the treatment of depressions. N Engl J Med 1948, 239:1036–1038.

    Article  PubMed  CAS  Google Scholar 

  51. Itil TM, Michael ST, Shapiro DM, Itil KZ: The effects of mesterolone, a male sex hormone in depressed patients (a double blind controlled study). Meth Find Exp Clin Pharmacol 1984, 6:331–337.

    CAS  Google Scholar 

  52. Itil TM, Herrmann WM, Blasucci D, Freedman A: Male hormones in the treatment of depression: effects of mesterolone. Prog Neuropsychopharmacol 1978, 2:457–467.

    Article  Google Scholar 

  53. Vogel W, Klaiber EL, Broverman DM: A comparison of the antidepressant effects of a synthetic androgen (mesterolone) and amitriptyline in depressed men. J Clin Psychiatry 1985, 46:6–8.

    PubMed  CAS  Google Scholar 

  54. Vogel W, Klaiber EL, Broverman DM: Roles of the gonadal steroid hormones in psychiatric depression in men and women. Prog Neuro-Psychopharmacol 1978, 2:487–503.

    Article  Google Scholar 

  55. Seidman SN, Roose SP: Testosterone replacement for male depression: randomized clinical trial [abstract]. American Psychiatric Association 150th Annual Meeting, Chicago, IL, May 15, 2000.

  56. Williams JBW: A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry 1988, 44:742–747.

    Google Scholar 

  57. Pope HGJ, Katz DL: Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. Arch Gen Psychiatry 1994, 51:375–382.

    PubMed  CAS  Google Scholar 

  58. Uzych L: Anabolic-androgenic steroids and psychiatricrelated effects: a review. Can J Psychiatry 1992, 37:23–28.

    PubMed  CAS  Google Scholar 

  59. Pope HGJ, Kouri EM, Hudson JI: Effects of supraphysiologic doses of testosterone on mood and aggression in normal men. A randomized controlled trial. Arch Gen Psychiatry 2000, 57:133–140.

    Article  PubMed  CAS  Google Scholar 

  60. Yates WR, Perry P, Macindoe J, et al.: Psychosexual effects of three doses of testosterone in cycling and normal men. Biol Psychiatry 1999, 45:254–260.

    Article  PubMed  CAS  Google Scholar 

  61. Su TP, Pagliaro M, Schmidt PJ, et al.: Neuropsychiatric effects of anabolic steroids in male normal volunteers. J Am Med Assoc 1993, 269:2760–2764.

    Article  CAS  Google Scholar 

  62. Warnock JK, Bundren JC, Morris DW: Female hypoactive sexual desire disorder due to androgen deficiency: clinical and psychometric issues. Psychopharmacol Bull 1997, 33:761–766.

    PubMed  CAS  Google Scholar 

  63. Morris NM, Udry R, Khan-Dawood F, Dawood MY: Marital sex frequency and midcycle female testosterone. Arch Sex Behav 1987, 16:27–37.

    Article  PubMed  CAS  Google Scholar 

  64. Persky H, Dreisibach L, Miller WR, et al.: The relation of plasma androgen levels to sexual behaviors and attitudes of women. Psychosom Med 1982, 44:305–319.

    PubMed  CAS  Google Scholar 

  65. Bancroft J, Sanders D, Davidson D, Warner P: Mood, sexuality, hormones and the menstrual cycle: III. Sexuality and the role of androgens. Psychosom Med 1983, 45:509–516.

    PubMed  CAS  Google Scholar 

  66. Schreiner-Engel P, Schiavi RC, Smith H, White D: Sexual arousability and the menstrual cycle. Psychosom Med 1981, 43:199–214.

    PubMed  CAS  Google Scholar 

  67. Waxenberg SE, Drellich MG, Sutherland AM: Changes in female sexuality after adrenalectomy. J Clin Endocrinol Metab 1959, 19:193–202.

    PubMed  CAS  Google Scholar 

  68. Gelfand MM: Role of androgens in surgical menopause. Am J Obstet Gynecol 1999, 180:325–327.

    Article  Google Scholar 

  69. Leiblum SR, Bachmann G, Kemmann E, et al.: Vaginal atrophy in the postmenopausal woman: the importance of sexual activity and hormones. J Am Med Assoc 1983, 249:2195–2198.

    Article  CAS  Google Scholar 

  70. Bancroft J, Cawood EHH: Androgens and the menopause: a study of 40–60 year old women. Clin Endocrinol 1996, 45:577–587.

    Article  CAS  Google Scholar 

  71. Bachmann G, Leiblum SR: Sexuality in sexagenarian women. Maturitas 1991, 13:45–50.

    Article  Google Scholar 

  72. Sherwin BB: Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord 1988, 14:177–187.

    Article  PubMed  CAS  Google Scholar 

  73. Tuiten A, Van Honk J, Koppeschaar H, et al.: Time course and effects of testosterone administration on sexual arousal in women. Arch Gen Psychiatry 2000, 57:149–153.

    Article  PubMed  CAS  Google Scholar 

  74. Burger HG, Hailes J, Nelson JC, Menelaus M: Effect of combined implants of estradiol and testosterone on libido in postmenopausal women. Br Med J 1987, 294:936–937.

    CAS  Google Scholar 

  75. Brincat M, Magos A, Studd JWW: Subcutaneous hormone implants for the control of climacteric symptoms: a prospective study. Lancet 1984, 1:16–18.

    Article  PubMed  CAS  Google Scholar 

  76. Myers LS, Dixen J, Morrissette D, et al.: Effect of oestrogen, androgen, and progestin on sexual psychophysiology and behavior in postmenopausal women: a comparative study. J Clin Endocrinol Metab 1990, 70:1124–1131.

    Article  PubMed  CAS  Google Scholar 

  77. Montgomery JC, Appleby L, Brincat M, et al.: Effect of oestrogen and testosterone implants on psychological disorders of the climacteric. Lancet 1987, 339:297–299.

    Article  Google Scholar 

  78. Sand R, Studd JWW: Exogenous androgens in postmenopausal women. Am J Med 1995, 98:76S-79S.

    Article  Google Scholar 

  79. Labrie F, Diamond P, Cusan L, et al.: Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 1997, 82:3498–3505.

    Article  PubMed  CAS  Google Scholar 

  80. Katz DL, Morales AJ: Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DS) as therapeutic options in menopause. Semin Reprod Endocrinol 1998, 16:161–170.

    Article  PubMed  CAS  Google Scholar 

  81. Arlt W, Callies F, Van Vlijmen JC, et al.: Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999, 341:1013–1020.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Columbia University College of Physicians & Surgeons, 1051 Riverside Drive, Unit 98, 10032, New York, NY, USA

    Stuart N. Seidman MD

Authors
  1. Stuart N. Seidman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seidman, S.N. Hormonal aspects of sexual dysfunction: The therapeutic use of exogenous androgens in men and women. Curr Psychiatry Rep 2, 215–222 (2000). https://doi.org/10.1007/s11920-996-0011-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-996-0011-5

Keywords

Search

Navigation